Valuation: UCB

Market Cap 45.55B 52.06B 42.05B 38.71B 72.93B 5,016B 74.69B 503B 198B 2,455B 195B 191B 8,454B P/E 2026 *
25.6x
P/E 2027 * 20.4x
Enterprise Value 45.31B 51.78B 41.83B 38.5B 72.54B 4,989B 74.29B 500B 197B 2,442B 194B 190B 8,409B EV / Sales 2026 *
5.3x
EV / Sales 2027 * 4.48x
Free-Float
61.59%
Yield 2026 *
0.61%
Yield 2027 * 0.63%
1 day+0.67%
1 week+0.93%
Current month-8.66%
1 month-3.97%
3 months-9.32%
6 months-9.90%
Current year+0.29%
1 week 230.7
Extreme 230.7
239.3
1 month 230.7
Extreme 230.7
268.3
Current year 223
Extreme 223
289.5
1 year 169.35
Extreme 169.35
289.5
3 years 65.4
Extreme 65.4
289.5
5 years 65.4
Extreme 65.4
289.5
10 years 54.84
Extreme 54.84
289.5
Manager TitleAgeSince
Chief Executive Officer 67 2014-12-31
Director of Finance/CFO 59 2020-06-30
Chief Tech/Sci/R&D Officer 59 2024-04-30
Director TitleAgeSince
Director/Board Member 55 2011-12-31
Director/Board Member 67 2014-12-31
Director/Board Member 56 2014-04-23
Date Insider Type Main position Quantity % Market Cap.
1/15/26 Buy

Director

500 0.0003%
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+0.67%+0.93%+36.86%+197.49% 52.13B
-0.33%+1.83%+24.73%-6.86% 68.85B
+0.94%+39.60%+39.60%+39.60% 43.46B
+1.12%+0.35%-52.09%-53.39% 41.24B
-1.40%+3.43%+64.81%-25.41% 30.41B
-2.11%-9.45%+97.76%-49.58% 24.53B
+0.51%+0.46%+72.78%+90.09% 23.42B
-5.57%-0.84%-0.11%+182.38% 19.75B
-0.86%-1.99%+70.03%+117.01% 16.57B
+1.34%-5.25%+74.97%+150.25% 15.95B
Average -0.57%-1.25%+42.93%+64.16% 33.63B
Weighted average by Cap. -0.26%-0.31%+34.57%+51.74%

Financials

2026 *2027 *
Net sales 8.54B 9.76B 7.89B 7.26B 13.68B 941B 14.01B 94.28B 37.08B 460B 36.66B 35.85B 1,585B 9.64B 11.02B 8.9B 8.19B 15.44B 1,062B 15.81B 106B 41.85B 520B 41.38B 40.47B 1,790B
Net income 1.77B 2.02B 1.63B 1.5B 2.83B 195B 2.9B 19.53B 7.68B 95.39B 7.6B 7.43B 328B 2.28B 2.6B 2.1B 1.93B 3.65B 251B 3.73B 25.13B 9.88B 123B 9.77B 9.56B 423B
Net Debt -242M -277M -224M -206M -388M -26.67B -397M -2.67B -1.05B -13.05B -1.04B -1.02B -44.95B -2.32B -2.65B -2.14B -1.97B -3.72B -256B -3.81B -25.64B -10.08B -125B -9.97B -9.75B -431B
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,765
Date Price Change Volume
26-07-17 €239.30 +0.67% 93,109
26-07-16 €237.70 +0.85% 128,758
26-07-15 €235.70 +1.38% 167,608
26-07-14 €232.50 -1.32% 152,960
26-07-13 €235.60 -0.63% 192,311
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
239.30EUR
Average target price
287.95EUR
Spread / Average Target
+20.33%

Quarterly revenue - Rate of surprise